Invivyd, Inc. (IVVD)
0.6034
+0.04
(+7.18%)
USD |
NASDAQ |
Nov 09, 13:59
Invivyd Market Cap : 177.86M for Nov. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 165.95M |
| November 05, 2026 | 172.43M |
| November 04, 2026 | 186.76M |
| November 03, 2026 | 171.40M |
| November 02, 2026 | 171.55M |
| October 30, 2026 | 171.46M |
| October 29, 2026 | 177.44M |
| October 28, 2026 | 181.75M |
| October 27, 2026 | 173.52M |
| October 26, 2026 | 173.67M |
| October 23, 2026 | 180.80M |
| October 22, 2026 | 179.83M |
| October 21, 2026 | 188.44M |
| October 20, 2026 | 187.64M |
| October 19, 2026 | 179.80M |
| October 16, 2026 | 182.34M |
| October 15, 2026 | 197.13M |
| October 14, 2026 | 179.15M |
| October 13, 2026 | 190.41M |
| October 12, 2026 | 198.46M |
| October 09, 2026 | 212.58M |
| October 08, 2026 | 206.45M |
| October 07, 2026 | 214.76M |
| October 06, 2026 | 237.69M |
| October 05, 2026 | 247.36M |
| Date | Value |
|---|---|
| October 02, 2026 | 242.32M |
| October 01, 2026 | 240.67M |
| September 30, 2026 | 256.47M |
| September 29, 2026 | 250.57M |
| September 28, 2026 | 280.02M |
| September 25, 2026 | 275.36M |
| September 24, 2026 | 269.20M |
| September 23, 2026 | 272.09M |
| September 22, 2026 | 284.14M |
| September 21, 2026 | 300.65M |
| September 18, 2026 | 222.63M |
| September 17, 2026 | 219.95M |
| September 16, 2026 | 237.37M |
| September 15, 2026 | 244.65M |
| September 14, 2026 | 262.86M |
| September 11, 2026 | 231.53M |
| September 10, 2026 | 228.70M |
| September 09, 2026 | 235.01M |
| September 08, 2026 | 243.41M |
| September 04, 2026 | 243.47M |
| September 03, 2026 | 246.12M |
| September 02, 2026 | 236.98M |
| September 01, 2026 | 259.36M |
| August 31, 2026 | 281.46M |
| August 28, 2026 | 284.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lineage Cell Therapeutics, Inc. | 268.08M |
| Armata Pharmaceuticals, Inc. | 135.95M |
| Voyager Therapeutics, Inc. | 121.93M |
| Black Diamond Therapeutics, Inc. | 108.00M |
| Elicio Therapeutics, Inc. | 37.89M |
Market Cap Related Metrics
| PS Ratio | 2.797 |
| Price to Book Value | 0.9822 |
| Price | 0.6034 |
| Earnings Yield | -61.82% |